Table 1 Baseline characteristics among CXRT and non-CXRT patients
Parameters | CXRT (n-43) | Non CXRT (n-141) | P value |
|---|---|---|---|
Clinical variables | |||
Age | 80.9 ± 8.3 | 81.5 ± 9.2 | 0.72 |
BMI | 26.9 ± 6.1 | 28.5 ± 6.2 | 0.14 |
Female, % | 69.7 | 49.6 | 0.02* |
White, % | 95.4 | 93.6 | 0.39 |
STS score, mean | 8.6 ± 4.5 | 8.3 ± 4.4 | 0.67 |
HTN, % | 83.7 | 85.1 | 0.81 |
DM,% | 34.8 | 29.7 | 0.57 |
HLD, % | 69.7 | 56.0 | 0.12 |
Smoking, % | 65.1 | 41.1 | 0.008* |
CVA, % | 55.8 | 4.3 | < 0.0001* |
COPD, % | 34.9 | 43.3 | 0.38 |
CAD, % | 62.8 | 51.1 | 0.22 |
ESRD, % | 9.3 | 4.9 | 0.23 |
PAD, % | 25.6 | 37.6 | 0.20 |
CABG, % | 32.6 | 22.0 | 0.11 |
Cardiac surgery, % | 32.7 | 26.2 | 0.44 |
3-coronary vessel disease, % | 27.9 | 24.8 | 0.69 |
Ischemic cardiomyopathy (EF < 50%), % | 14.0 | 19.1 | 0.50 |
Angina, % | 34.9 | 28.4 | 0.45 |
Syncope, % | 4.7 | 5.7 | 1.00 |
Lab variables | |||
Creatinine in mg/dl, mean | 1.3 ± 1.0 | 1.3 ± 1.0 | 0.98 |
FEV1, mean | 79.6 ± 24.7 | 74.1 ± 24.4 | 0.19 |
eGFR, mean | 52.9 ± 22.5 | 53.9 ± 21.1 | 0.78 |
Medications | |||
Aspirin, % | 81.6 | 61.7 | 0.02* |
ACEI/ARB, % | 21.1 | 35.5 | 0.11 |
Beta-blocker, % | 75.6 | 78.7 | 0.67 |
Statins, % | 69.8 | 56.0 | 0.11 |
Echo Variables | |||
LVEF, mean | 57.6 ± 11.7 | 55.2 ± 13.4 | 0.29 |
Mean AV gradient | 45.4 ± 14.7 | 43.8 ± 15.3 | 0.54 |
Mod-severe MS, % | 13.9 | 3.6 | 0.02 * |
Mod-severe MR, % | 23.3 | 14.2 | 0.16 |
Mod-severe AR, % | 18.6 | 14.2 | 0.47 |
Mod-severe TR, % | 16.3 | 11.3 | 0.43 |